IA
NVCT icon

IFP Advisors’s Nuvectis Pharma NVCT Stock Holding History

IFP Advisors’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.66K Buy
+90
New +$1.01K ﹤0.01% 4317

Other funds holding NVCT

BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
AWM
Austin Wealth Management Austin, Texas $473M AUM 18.73% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

IFP Advisors's NVCT Position: Q2 2026 in Review

IFP Advisors opened a new position in Nuvectis Pharma (NVCT) in Q2 2026: 90 shares worth $1.66K. The stake represents ﹤0.01% of the portfolio and ranks #4317 among its holdings.

9 funds tracked by Wall St. Rank hold NVCT as of Q2 2026.

  • IFP Advisors held 90 shares of Nuvectis Pharma worth $1.66K as of Q2 2026.
  • Nuvectis Pharma was a new IFP Advisors position in Q2 2026.
  • Nuvectis Pharma made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4317 holding.
  • 9 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.